MedTrace Logo

Autologous Cord Blood Cells for Prevention of BPD in Preterm

NCT04311476 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2020-06-02

No results posted yet for this study

Summary

To study the effect of Autologous cord blood cells infusion on prevention of bronchopulmonary dysplasia in very preterm neonates

Conditions

  • Safety Issues
  • BPD - Bronchopulmonary Dysplasia
  • Neonatal Death

Interventions

OTHER

Autologous Umbilical Cord Blood Mononuclear Cells infusion Therapy

Evaluate Autologous cord blood cells infusion on prevention of bronchopulmonary dysplasia in very preterm neonates

DRUG

0.9% Sodiun Chloride

0.9% Sodiun Chloride in control group

Sponsors & Collaborators

  • yangjie

    lead OTHER

Principal Investigators

  • Jie Yang, PHD · Guangdong Women and Children Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
28 Weeks
Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-07-01
Primary Completion
2020-01-01
Completion
2020-01-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04311476 on ClinicalTrials.gov